Rewriting the Script: How SGLT2 Inhibitors Are Transforming Heart Failure Care

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Review highlights cardiovascular and renal benefits of SGLT2 inhibitors in heart failure, suggesting their vital role in care strategies.

SGLT2 inhibitors significantly improve heart failure patient outcomes, reducing hospitalizations and mortality.
Key trials, including DAPA-HF and EMPEROR studies, demonstrate their positive effects on heart failure management.
This review involves an examination of evolving roles for SGLT2 inhibitors based on recent clinical findings.
Their use promotes better quality of life and symptom relief in heart failure patients, indicating a shift in treatment paradigms.

Shaik et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark